To assess the immune system involvement, many authors evaluated the circulating levels of IL-6, TNF-α, and IFNγ production in AD patient serum/plasma [53, 98, 99], CSF (cerebrospinal fluid) [100], and derived peripheral blood mononuclear cells [101]. The gene discussed is IL6; the disease is Alzheimer disease.